Selected research
Industry Research
Orthopedic Hyaluronic Acid Viscosupplementation Industry Research Report 2026
Market perspective
The global Orthopedic Hyaluronic Acid Viscosupplementation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Orthopedic Hyaluronic Acid Viscosupplementation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Orthopedic Hyaluronic Acid Viscosupplementation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation include Haohai Biological, Sanofi, Shanghai Jingfeng, Ferring, Zimmer Biomet, Seikagaku, LG Chem, Freda and Bioventus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Orthopedic Hyaluronic Acid Viscosupplementation market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Orthopedic Hyaluronic Acid Viscosupplementation Market by Company
Haohai Biological
Sanofi
Shanghai Jingfeng
Ferring
Zimmer Biomet
Seikagaku
LG Chem
Freda
Bioventus
Anika Therapeutics
Orthopedic Hyaluronic Acid Viscosupplementation Segment by Type
Five Injection
Three Injection
Single Injection
Orthopedic Hyaluronic Acid Viscosupplementation Segment by Application
Hospitals
Clinics
Others
Orthopedic Hyaluronic Acid Viscosupplementation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedic Hyaluronic Acid Viscosupplementation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orthopedic Hyaluronic Acid Viscosupplementation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthopedic Hyaluronic Acid Viscosupplementation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Orthopedic Hyaluronic Acid Viscosupplementation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Orthopedic Hyaluronic Acid Viscosupplementation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Orthopedic Hyaluronic Acid Viscosupplementation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Five Injection
- Three Injection
- Single Injection
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Haohai Biological
- Sanofi
- Shanghai Jingfeng
- Ferring
- Zimmer Biomet
- Seikagaku
- LG Chem
- Freda
- Bioventus
- Anika Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size (2021-2032)
- 2.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales (2021-2032)
- 2.2.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Average Price (2021-2032)
- 2.3 Orthopedic Hyaluronic Acid Viscosupplementation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Five Injection
- 2.3.3 Three Injection
- 2.3.4 Single Injection
- 2.4 Orthopedic Hyaluronic Acid Viscosupplementation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue of Manufacturers (2021-2026)
- 3.4 Global Orthopedic Hyaluronic Acid Viscosupplementation Average Price by Manufacturers (2021-2026)
- 3.5 Global Orthopedic Hyaluronic Acid Viscosupplementation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation, Product Type & Application
- 3.8 Global Manufacturers of Orthopedic Hyaluronic Acid Viscosupplementation, Established Date
- 3.9 Global Orthopedic Hyaluronic Acid Viscosupplementation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Haohai Biological
- 4.1.1 Haohai Biological Company Information
- 4.1.2 Haohai Biological Business Overview
- 4.1.3 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Haohai Biological Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.1.5 Haohai Biological Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Shanghai Jingfeng
- 4.3.1 Shanghai Jingfeng Company Information
- 4.3.2 Shanghai Jingfeng Business Overview
- 4.3.3 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Jingfeng Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.3.5 Shanghai Jingfeng Recent Developments
- 4.4 Ferring
- 4.4.1 Ferring Company Information
- 4.4.2 Ferring Business Overview
- 4.4.3 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.4.5 Ferring Recent Developments
- 4.5 Zimmer Biomet
- 4.5.1 Zimmer Biomet Company Information
- 4.5.2 Zimmer Biomet Business Overview
- 4.5.3 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.5.5 Zimmer Biomet Recent Developments
- 4.6 Seikagaku
- 4.6.1 Seikagaku Company Information
- 4.6.2 Seikagaku Business Overview
- 4.6.3 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Seikagaku Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.6.5 Seikagaku Recent Developments
- 4.7 LG Chem
- 4.7.1 LG Chem Company Information
- 4.7.2 LG Chem Business Overview
- 4.7.3 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LG Chem Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.7.5 LG Chem Recent Developments
- 4.8 Freda
- 4.8.1 Freda Company Information
- 4.8.2 Freda Business Overview
- 4.8.3 Freda Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Freda Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.8.5 Freda Recent Developments
- 4.9 Bioventus
- 4.9.1 Bioventus Company Information
- 4.9.2 Bioventus Business Overview
- 4.9.3 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.9.5 Bioventus Recent Developments
- 4.10 Anika Therapeutics
- 4.10.1 Anika Therapeutics Company Information
- 4.10.2 Anika Therapeutics Business Overview
- 4.10.3 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Product Portfolio
- 4.10.5 Anika Therapeutics Recent Developments
5 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Scenario by Region
- 5.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021-2032
- 5.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2021-2026
- 5.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Region: 2027-2032
- 5.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2021-2032
- 5.3.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2021-2026
- 5.3.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Region: 2027-2032
- 5.4 North America Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
- 5.4.1 North America Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
- 5.4.3 North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
- 5.5.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
- 5.5.3 Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
- 5.6.1 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
- 5.7.1 South America Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
- 5.7.3 South America Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021-2032)
- 6.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2021-2032)
- 6.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Type (2021-2032)
- 6.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2021-2032)
- 6.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021-2032)
- 7.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2021-2032)
- 7.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Application (2021-2032)
- 7.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2021-2032)
- 7.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Orthopedic Hyaluronic Acid Viscosupplementation Value Chain Analysis
- 8.1.1 Orthopedic Hyaluronic Acid Viscosupplementation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Orthopedic Hyaluronic Acid Viscosupplementation Production Mode & Process
- 8.2 Orthopedic Hyaluronic Acid Viscosupplementation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Orthopedic Hyaluronic Acid Viscosupplementation Distributors
- 8.2.3 Orthopedic Hyaluronic Acid Viscosupplementation Customers
9 Global Orthopedic Hyaluronic Acid Viscosupplementation Analyzing Market Dynamics
- 9.1 Orthopedic Hyaluronic Acid Viscosupplementation Industry Trends
- 9.2 Orthopedic Hyaluronic Acid Viscosupplementation Industry Drivers
- 9.3 Orthopedic Hyaluronic Acid Viscosupplementation Industry Opportunities and Challenges
- 9.4 Orthopedic Hyaluronic Acid Viscosupplementation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst